Fisher Asset Management LLC Has $6.43 Million Stock Position in Silicon Laboratories Inc. (NASDAQ:SLAB)

Fisher Asset Management LLC raised its holdings in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 20.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 55,640 shares of the semiconductor company's stock after purchasing an additional 9,566 shares during the period. Fisher Asset Management LLC owned about 0.17% of Silicon Laboratories worth $6,430,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of SLAB. CWM LLC increased its position in Silicon Laboratories by 185.0% in the second quarter. CWM LLC now owns 8,435 shares of the semiconductor company's stock worth $933,000 after buying an additional 5,475 shares during the period. SG Americas Securities LLC boosted its stake in Silicon Laboratories by 284.6% during the 2nd quarter. SG Americas Securities LLC now owns 7,076 shares of the semiconductor company's stock valued at $783,000 after purchasing an additional 5,236 shares during the period. Clearbridge Investments LLC grew its position in Silicon Laboratories by 84.0% in the 2nd quarter. Clearbridge Investments LLC now owns 273,776 shares of the semiconductor company's stock worth $30,288,000 after purchasing an additional 125,022 shares during the last quarter. Intech Investment Management LLC raised its holdings in shares of Silicon Laboratories by 82.9% during the third quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company's stock valued at $1,484,000 after buying an additional 5,818 shares during the last quarter. Finally, Premier Fund Managers Ltd acquired a new position in shares of Silicon Laboratories during the third quarter worth approximately $934,000.

Insider Activity at Silicon Laboratories

In other news, SVP Brandon Tolany sold 845 shares of Silicon Laboratories stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $115.00, for a total value of $97,175.00. Following the transaction, the senior vice president now directly owns 43,615 shares of the company's stock, valued at $5,015,725. This trade represents a 1.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.72% of the stock is currently owned by corporate insiders.

Silicon Laboratories Trading Up 1.7 %

SLAB stock traded up $1.87 on Friday, hitting $110.65. 120,653 shares of the company's stock traded hands, compared to its average volume of 298,100. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of -14.70 and a beta of 1.20. Silicon Laboratories Inc. has a 1-year low of $94.00 and a 1-year high of $154.91. The stock has a fifty day moving average of $110.94 and a 200-day moving average of $113.71.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.07. The company had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The company's quarterly revenue was down 18.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.48 EPS. On average, equities research analysts anticipate that Silicon Laboratories Inc. will post -3.56 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have weighed in on SLAB shares. JPMorgan Chase & Co. cut their target price on Silicon Laboratories from $150.00 to $135.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 5th. KeyCorp reduced their price objective on shares of Silicon Laboratories from $150.00 to $115.00 and set an "overweight" rating for the company in a report on Tuesday, November 5th. StockNews.com raised shares of Silicon Laboratories to a "sell" rating in a research note on Friday, November 8th. Barclays reduced their price target on shares of Silicon Laboratories from $120.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 5th. Finally, Morgan Stanley lowered their price objective on shares of Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating on the stock in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $121.50.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.